Zhejiang Sunflower Great Health Stock Forum

Investors are hoping for a turnaround in the company's business prospects due to its high P/S ratio and poor growth rate. However, if recent medium-term revenue trends persist, the stock value may not be sustainable.

Despite medium-term revenue decline, high P/S ratio could disappoint shareholders if it aligns with declining growth. Potential investors should be wary of stock's overvaluation and overly bullish sentiments. Continuous decline could pose risk to investments.